Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

被引：0

作者：

Laure Gossec

Stefan Siebert

Paul Bergmans

Kurt de Vlam

Elisa Gremese

Beatríz Joven-Ibáñez

Tatiana V. Korotaeva

Frederic Lavie

Wim Noël

Michael T. Nurmohamed

Petros P. Sfikakis

Mohamed Sharaf

Elke Theander

Josef S. Smolen

机构：

[1] Sorbonne Université,Rheumatology Department

[2] INSERM,Fondazione Policlinico A Gemelli

[3] Institut Pierre Louis d’Epidémiologie et de Santé Publique,IRCCS

[4] Pitié-Salpêtrière Hospital,undefined

[5] APHP,undefined

[6] 47–83 Boulevard de l’Hôpital,undefined

[7] University of Glasgow,undefined

[8] Janssen-Cilag BV,undefined

[9] University Hospitals Leuven,undefined

[10] Università Cattolica del Sacro Cuore,undefined

[11] University Hospital,undefined

[12] VA Nasonova Research Institute of Rheumatology,undefined

[13] The Janssen Pharmaceutical Companies of Johnson & Johnson,undefined

[14] Janssen Pharmaceutica NV,undefined

[15] Reade and VU University Medical Center,undefined

[16] National and Kapodistrian University of Athens Medical School,undefined

[17] Johnson and Johnson MEA,undefined

[18] Janssen,undefined

[19] Present address: Malmö University Hospital,undefined

[20] Medical University of Vienna,undefined

来源：

Arthritis Research & Therapy | / 25卷

关键词：

Patient-reported outcomes; Psoriatic arthritis; Real-world evidence; Tumour necrosis factor inhibitor; Ustekinumab;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 38 条

[21] Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology–Rheumatology clinic: a retrospective real-world study
Kalliopi Klavdianou
Maria Stavropoulou
Pantelis Panagakis
Marina Papoutsaki
Alexandros Panagiotopoulos
Christos Koutsianas
Alexandros Stratigos
Dimitrios Rigopoulos
Dimitrios Vassilopoulos
Rheumatology International, 2022, 42 : 1035 - 1041
[22] Patient-reported outcomes and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study
Murrell, Dedee F.
Ferrucci, Silvia M.
Foti, Caterina
Perez-Garcia, Bibiana
Lapeere, Hilde
Calzavara-Pinton, Piergiacomo
Fougerousse, Anne-Claire
Wu, Jiangming
Ardeleanu, Marius
Bosman, Kwinten
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[23] Treatment patterns, effectiveness, and patient-reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real-world study
Shen, Lesang
Zhou, Jun
Chen, Yiding
Ding, Jinhua
Wei, Haiyan
Liu, Jian
Xia, Wenjie
Xie, Bojian
Xie, Xiaohong
Li, Xujun
Dai, Yuechu
Zhang, Guobing
Qiu, Xia
Li, Chao
Sun, Shanshan
Chen, Wuzhen
Gong, Dihe
Li, Hengyu
Huang, Jian
Jiang, Xia
Ni, Chao
CANCER MEDICINE, 2022, 11 (22): : 4157 - 4168
[24] Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
Shimizu, Hiromichi
Aonuma, Yuko
Hibiya, Shuji
Kawamoto, Ami
Takenaka, Kento
Fujii, Toshimitsu
Saito, Eiko
Nagahori, Masakazu
Ohtsuka, Kazuo
Okamoto, Ryuichi
INTESTINAL RESEARCH, 2024, 22 (03) : 369 - 377
[25] Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study
Klavdianou, Kalliopi
Stavropoulou, Maria
Panagakis, Pantelis
Papoutsaki, Marina
Panagiotopoulos, Alexandros
Koutsianas, Christos
Stratigos, Alexandros
Rigopoulos, Dimitrios
Vassilopoulos, Dimitrios
RHEUMATOLOGY INTERNATIONAL, 2022, 42 (06) : 1035 - 1041
[26] Improving Clinical Management and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis in China via Real-world Evidence (IMPROVE Study): A Multicenter Prospective Cohort Study
Nan Jiang
Dongzhou Liu
Xinwang Duan
Lijun Wu
Yi Liu
Hao Zhu
Yanjie Zhang
Mengtao Li
Xinping Tian
Xiaofeng Zeng
Advances in Therapy, 2025, 42 (6) : 2906 - 2921
[27] Treatment efficacy and patient satisfaction of ustekinumab compared with tumor necrosis factor-alpha inhibitors in Chinese patients with moderate-to-severe psoriasis: a real-world study
Guo, Bin
Jin, Xiaobo
Fan, Leiqiang
Zhang, Yanfeng
Xu, Bing
Yang, Tao
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[28] OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY
Schmalzing, M.
Askari, A.
Sheeran, T.
Jathanakodi, S.
Both, C.
Kellner, H.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1397 - 1397
[29] Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
Griffiths, C. E. M.
Vender, R.
Sofen, H.
Kircik, L.
Tan, H.
Rottinghaus, S. T.
Bachinsky, M.
Mallbris, L.
Mamolo, C.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) : 323 - 332
[30] SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION UP TO 1 YEAR
Coates, L.
Landewe, R. B. M.
Mcinnes, I.
Mease, P. J.
Ritchlin, C. T.
Tanaka, Y.
Asahina, A.
Behrens, F.
Gladman, D. D.
Gossec, L.
Gottlieb, A. B.
Warren, R. B.
Ink, B.
Bajracharya, R.
Coarse, J.
Merola, J. F.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 346 - 347

← 1 2 3 4 →